FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Medroxyprogesterone Acetate (Depo-Provera) Injection, Suspension
Status: Discontinuation
»Therapeutic Categories: Reproductive

Pfizer Pharmaceuticals (New 10/27/2020)

Company Contact Information:

Presentation Posting Date Related Information
400 mg/mL, 1 carton containing one 2.5 mL vial (NDC 0009-0626-01) 10/27/2020 Discontinuation of the manufacturing of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English